[Market Focus] AP Healthcare Surges on Plans to Enter Virtual Asset Business

As of 9:30 a.m. on August 11, AP Healthcare's stock price on the KOSDAQ market was up by the daily limit of 30.0% from the previous trading day's closing price, reaching 455 won. This surge appears to be due to the company's announcement of changes to its articles of incorporation and corporate name, as well as its plan to enter the cryptocurrency business.

AP Healthcare's main businesses include the distribution and sale of pharmaceuticals, such as topical agents, gastrointestinal drugs, tonics, and antibiotics, as well as a leasing business involving its real estate, machinery, and equipment. The company's largest shareholders are Aprogen (48.78%) and Aprogen Biologics (20.06%).

On August 6, AP Healthcare announced that it would hold an extraordinary general meeting of shareholders on August 22 to add the following items to its business objectives in the articles of incorporation: blockchain and virtual asset-related businesses; blockchain and virtual asset investment businesses; blockchain and virtual asset financial businesses; and all businesses and services incidental to the above, including installation and construction services. The company also announced that it would change its name to APTOCROM Co., Ltd.

Previously, in the KOSDAQ market, stock prices surged after the largest shareholders of Hyper Corporation and Bridge Biotherapeutics changed to foreign virtual asset companies, and after Someage declared its entry into the cryptocurrency business through amendments to its articles of incorporation.

This content was produced with the assistance of AI translation services.